The interesting comparative study' of the effect of anticoagulant choice on measured total antioxidant activity (TAA) did not refer to the use of serum. I prefer to use serum or otherwise acid citrate dextrose as anticoagulant. Heparinized blood is convenient for immediate centrifugation, but stored frozen heparinized plasma samples produce fibrin clots on thawing to which analytes of interest may adsorb! I have not found any significant difference between TAA values on fresh heparinized plasma and serum (n = 30) using the ABTS method. 3 TAA is stable in unseparated blood for at least 6 h at room temperature, indicating that the time taken for clotting will not affect the result.
Heparin is not an antioxidant in the sense that it does not possess hydrogen-donating antioxidant activity: it will react with hydroxyl radicals, which reflects their extreme reactivity rather than a specific property of heparin. In contrast, EDTA does possess weak hydrogen-donating antioxidant activity (distinct from its activity as a metal chelator); 3 this is, however, unlikely to be significant in plasma at the EDTA concentration at which it is used as an anticoagulant.
A wide variety of samples may therefore be suitable for this assay, so long as they are measured without extended storage in the freezer. Author's reply
We welcome the comments by Dr Miller on our recent paper. 1 Heparinized plasma is used commonly for the reasons he suggests. The samples used in the present assay were only stored for a maximum of 1 month, and were usually assayed within 1 week of sampling. In clinical situations it is often the case that samples cannot be assayed immediately. For example, in our own studies of patients during liver transplantation? and intensive care patients with sepsis;' it is simply not feasible to perform assays immediately after sampling, and waiting for 6 h whilst clotting occurs is unpopular at 0200 h! Therefore, the choice of sampling conditions becomes a realistic balance encompassing necessity, desirability and practicality. Antioxidants should not be classed by their ability to donate hydrogen ions, but rather by their role in protection against oxidative damage, including catalytic scavenging and sacrificial destruction. Thus, the statement in our paper! in which heparin may have antioxidant properties and protects endothelial cells from antioxidant damage in vitro, regardless of mechanism, remains valid. Despite the suggestion that the levels of anticoagulants in plasma samples are unlikely to be significant, we have clearly shown that they do have a significant effect on total antioxidant capacity, and therefore the choice of anticoagulant, if any, should be consistent.
